Russell T Ray's Net Worth

$33.8 Million

Estimate Recalculated Jul 17, 2024 03:18PM EST

Who is Russell T Ray?

Russell T Ray has an estimated net worth of $33.8 Million. This is based on reported shares across multiple companies, which include TANDEM DIABETES CARE INC, 180 Life Sciences Corp., MERRIMACK PHARMACEUTICALS INC, ALLERGAN INC, and CombiMatrix Corp.

SEC CIK

Russell T Ray's CIK is 0001225960

Past Insider Trading and Trends

2022 was Russell T Ray's most active year for acquiring shares with 7 total transactions. Russell T Ray's most active month to acquire stocks was the month of April. 2015 was Russell T Ray's most active year for disposing of shares, totalling 7 transactions. Russell T Ray's most active month to dispose stocks was the month of February. 2013 saw Russell T Ray paying a total of $3,000,000.00 for 1,657,160 shares, this is the most they've acquired in one year. In 2012 Russell T Ray cashed out on 48,000 shares for a total of $3,004,564.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TANDEM DIABETES CARE INC (TNDM) Snapshot price: $23.685

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.45M
—
—
1.45M
Nov 19
Form 4
∞
200K
$15.00
$3,000,000.00
200K
Nov 13
Form 3
—
0
—
—
0
No matching records found

CombiMatrix Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

180 Life Sciences Corp. (ATNF) Snapshot price: $0.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+726.30%
21.45K
$1.36
$29,178.80
24.41K
Sep 4
Form 4
+108.24%
30.7K
—
—
59.07K
Oct 31
Form 4
+85.42%
13.07K
—
—
28.37K
Jul 27
Form 4/A
+223.56%
10.57K
$1.36
$14,375.20
15.3K
May 19
Form 4
∞
10.57K
$1.36
$14,375.20
10.57K
May 19
Form 4
∞
4.73K
$3.04
$14,373.12
4.73K
Jan 14
Form 4
—
0
—
—
0
Aug 4
Form 3
—
0
—
—
0
No matching records found

MERRIMACK PHARMACEUTICALS INC (MACK) Snapshot price: $13.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.00K
$3.84
-$3,839.80
0
Dec 31
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jul 30
Form 4
—
0
—
—
0
Oct 17
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Sep 13
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
May 13
Form 3
—
0
—
—
0
No matching records found

ALLERGAN INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-27.17K
—
—
0
Mar 17
Form 4
+4.82%
1.25K
—
—
27.17K
May 6
Form 4
+13.60%
3.1K
—
—
25.91K
Apr 30
Form 4
-44.12%
-18.00K
$65.40
-$2,408,439.50
22.8K
Nov 21
Form 4
+13.33%
4.8K
—
—
40.8K
May 1
Form 4
—
0
—
—
0
Apr 29
Form 4
+133.33%
14.4K
—
—
25.2K
Apr 30
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
May 1
Form 4/A
—
0
—
—
0
May 2
Form 4
+100.00%
5.4K
—
—
10.8K
May 2
Form 4
—
0
—
—
0
Apr 26
Form 4
—
0
—
—
0
Apr 28
No matching records found